28.11.2017 Views

D-dimer Market

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

D-<strong>dimer</strong> <strong>Market</strong> analysis research and trends report for 2017-<br />

2024: Global <strong>Market</strong> Insights Inc.<br />

D-<strong>dimer</strong> <strong>Market</strong> size is projected to experience significant growth from 2017 to<br />

2024.Increasing demand for D-<strong>dimer</strong> tests due to high accuracy, cost effectiveness,<br />

and lack of radiological interventions will drive the global D-<strong>dimer</strong> market size. Growing<br />

prevalence of high level d-<strong>dimer</strong> in women at an early age due to higher burden of<br />

associated diseases will boost the industry size. Moreover, increase in occurrence of<br />

cardiovascular and pulmonary diseases coupled with growing demand for advanced<br />

coagulation testing techniques and rising lifestyle induced diseases will fuel the<br />

product demand over the forecast years.<br />

The increasing cost-containment pressures in major established nations and constant<br />

technological advances will radically change coagulation testing practice during the<br />

forecast period. Technological advancements have contributed majorly in reducing the<br />

cost associated with tests at POCs and laboratories. Stringent regulatory guidelines<br />

for listing of devices and manufacturing practice may hamper d-<strong>dimer</strong> market growth.<br />

Low specification when used in special setting such as in oncology patients, elderly<br />

patients, and pregnant women can limit industry size.<br />

Based on application, the industry is segmented into deep venous thrombosis testing,<br />

pulmonary embolism testing and disseminated intravascular coagulation testing.<br />

Pulmonary embolism testing market is estimated to dominate the industry due to its<br />

growing prevalence among geriatric population. Deep venous thrombosis (DVTs)<br />

testing is also likely to grow at a substantial rate over the forecast period.<br />

Pulmonary Embolism (PE) is the third-most-common cause of death in the U.S., after<br />

heart attack and stroke. According to American Society for Clinical Pathology,<br />

thromboembolic disease, which comprises DVTs, PEs, and associated medical<br />

complications, marks more than 600,000 people in the country each year and<br />

generates approximately USD 10 billion.<br />

Europe will experience a substantial growth with mounting clinical trial, technological<br />

advancement, and therapeutic practices. The National Health Service (NHS) records<br />

around 1 person in 1,000 with DVT in the U.K. every year. Increasing opportunities to<br />

implement rapid diagnostic testing to improve operations, improved health care<br />

awareness, and preference of the people for preventive health checkups will fuel the<br />

industry size.<br />

Asia Pacific is forecast to grow at highest rate with increasing number of patients<br />

demanding test for coagulation as well as introduction of more sensitive and specific<br />

markers of hemostasis on automated instruments. Diagnostic laboratories are facing<br />

1 | P a g e


challenges in delivering high-quality, efficient and timely testing solutions due to rising<br />

health care awareness and stringent regulations that pressurize health care budgets.<br />

Brazil d-<strong>dimer</strong> market will dominate Latin America during the forecast period due to<br />

rising incidence rates of cardiovascular diseases associated with changing lifestyle<br />

habits. South Africa witnessed the highest share in MEA region owing to growing<br />

elderly population, prevalence of higher d-<strong>dimer</strong> levels in black race and female sex.<br />

Some of the industry players in d-<strong>dimer</strong> market include Abbott Laboratories, F.<br />

Hoffman-La Roche, Beckman Coulter, Alere, Bio/Data, Becton Dickinson, Sysmex,<br />

Siemens Healthcare, Trinity Biotech and Thermo Fisher Scientific. Competition is<br />

growing among industry players across all regions with increasing technological<br />

advancements.<br />

2 | P a g e


About Global <strong>Market</strong> Insights<br />

Global <strong>Market</strong> Insights, Inc., headquartered in Delaware, U.S., is a global market<br />

research and consulting service provider; offering syndicated and custom research<br />

reports along with growth consulting services. Our business intelligence and industry<br />

research reports offer clients with penetrative insights and actionable market data<br />

specially designed and presented to aid strategic decision making. These exhaustive<br />

reports are designed via a proprietary research methodology and are available for key<br />

industries such as chemicals, advanced materials, technology, renewable energy and<br />

biotechnology.<br />

Contact Us:<br />

Arun Hegde<br />

Corporate Sales, USA<br />

Global <strong>Market</strong> Insights, Inc.<br />

Phone: 1-302-846-7766<br />

Toll Free 1-888-689-0688<br />

Email: sales@gminsights.com<br />

Website: https://www.gminsights.com<br />

Connect with us: Facebook | Google+ | LinkedIn | Twitter<br />

3 | P a g e

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!